Skip to content

Identification in Obese Patients of the Mechanism Involved in Intramuscular Lipid Accumulation

Identification in Obese Patients of the Mechanisms Involved in Intramuscular Lipid Accumulation.

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01644942
Enrollment
33
Registered
2012-07-19
Start date
2008-05-31
Completion date
2013-06-30
Last updated
2013-06-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hyperlipidemia, Insulin Resistance, Obesity

Keywords

Obese, insulin sensitive, insulin resistant, myotubes, lipid accumulation

Brief summary

The study aims to determine in obese patients the implication of intramuscular lipid accumulation in relation with insulin resistance and defect in lipid oxidation.

Detailed description

Obese insulin sensitive and obese insulin resistant patients undergo a glucose tolerance test, indirect calorimetry during exercise and muscular biopsy.

Interventions

OTHERLipid accumulation analysis

The lipid accumulation will be assessed with muscular biopsies.

Sponsors

University Hospital, Montpellier
Lead SponsorOTHER

Study design

Allocation
NON_RANDOMIZED
Intervention model
PARALLEL
Masking
NONE

Eligibility

Sex/Gender
MALE
Age
40 Years to 70 Years
Healthy volunteers
No

Inclusion criteria

* Obese patients with a Body Mass Index (BMI) between 30 and 40 kg/m2 * Patients who do not practice physical exercise (Voorips index \< 9) * Age between 40 and 70 years- Male gender * Fast blood glucose \<1,10 g/l and no hypoglycemic treatment * Signed informed consent * Social security affiliation * Absence of anti VIH, anti hepatitis C antibodies, and HBS antigen * Normal biological tests * Non smoking persons

Exclusion criteria

* Patients who refuse the anti-VIH, anti-hepatitis C antibodies, and HBS antigens tests * Patients treated by anticoagulant, b blockers, lipopenic, or anti-inflammatory. * Patients with a contraindication to muscular exercise (retinopathy, coronaropathy, nephropathy) and to muscular biopsy * Allergy to local anaesthetic

Design outcomes

Primary

MeasureTime frame
lipid accumulation in skeletal muscle1 month

Secondary

MeasureTime frame
lipid accumulation in myotubes from obese patients1 month

Countries

France

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026